WER Medical
WER Medical
Modern Liquid Skin Protectants (LSPs) have evolved from simple barriers to complex cyanoacrylate and silicone-based polymers. These formulations provide a 72-hour breathable shield that prevents Moisture-Associated Skin Damage (MASD) while maintaining high oxygen permeability (MVTR).
Our LSPs create an ultra-thin, transparent film that is alcohol-free and non-stinging. This "second skin" is designed to withstand mechanical friction and chemical irritants such as digestive enzymes in stoma care or harsh adhesives in long-term IV therapy.
WER Medical’s unique formulation includes biocompatible additives that reduce inflammation. Unlike traditional petroleum-based ointments, our liquid films do not clog pores or interfere with the absorbent properties of secondary dressings like silicone foam.
Smart Manufacturing Plant
Global Export Regions
Certified Compliance
Innovation Heritage
Since 2018, WER Medical has specialized in advanced medical wound dressings, focusing on silicone foam variants and liquid barrier technologies. Our fully automated facilities meet strict FDA / CE MDR and ISO 13485 standards, ensuring top-tier quality for hospitals and retailers worldwide.
Headquartered in Shenzhen with a 10,000㎡ cutting-edge plant in Guangzhou, we bridge the gap between R&D innovation and large-scale manufacturing. Our core foaming technology and liquid-state polymer synthesis enable safe, comfortable healing for patients suffering from chronic wounds and dermatological sensitivities.
We are committed to providing clients with top-quality products, fast delivery, and the most competitive prices. We believe medical technology enhances health, relieving patients from pain so all may equally enjoy life’s moments.
In North America and Europe, the aging population has increased the demand for Incontinence-Associated Dermatitis (IAD) prevention. Our LSPs provide a localized solution that integrates with standard nursing protocols, reducing the risk of pressure ulcers in long-term care facilities.
From preventing blisters in professional marathon runners to protecting sensitive skin from diaper rash in infants, our "no-sting" formula is the preferred choice for consumer health brands globally. The fast-drying nature allows for immediate clothing contact or secondary taping.
For workers exposed to frequent hand-washing or chemical irritants (e.g., laboratory staff, electronics assembly), our liquid skin protectants offer a durable chemical barrier that traditional lotions cannot match. It maintains skin barrier function without compromising manual dexterity.
Efficiency & Integration: Based in the heart of the Pearl River Delta, WER Medical leverages a world-class upstream supply chain for medical-grade raw materials. This proximity allows us to go from R&D prototype to mass production 40% faster than Western counterparts.
Cost-Effective Innovation: Our intelligent production lines—incorporating foaming, gluing, punching, and sterile packaging—minimize human error and waste. We offer "China Speed" with "International Quality," ensuring that global distributors can maintain lean inventory levels with reliable lead times.
Transitioning toward biodegradable liquid films derived from plant-based polymers to meet ESG goals for global hospital groups.
Integration of pH-sensitive indicators within the liquid film that change color to alert caregivers of early-stage infection or skin breakdown.
Developing LSPs that act as controlled-release vehicles for topical anesthetics or antimicrobial agents (e.g., silver ions).
WER Medical is a trusted China-based partner for high-quality medical supplies. We provide full customization of product size, shape, and outer packaging to meet the specific demands of your local market.
A: Our clinical-grade formulation uses a proprietary polymer blend that ensures a higher MVTR (Moisture Vapor Transmission Rate) and longer durability. It is specifically tested for Medical Adhesive-Related Skin Injury (MARSI) prevention in professional surgical settings.
A: We provide a comprehensive documentation suite, including Clinical Evaluation Reports (CER), MSDS, and biocompatibility testing (ISO 10993) to facilitate rapid registration with local health authorities like EMA or TGA.
A: While LSPs are primarily designed for periwound protection (the skin around the wound) and intact skin, our sterile versions can be used to protect fragile skin from exudate damage. Always consult the specific product IFU for direct wound bed contact instructions.
A: For customized packaging and sizing, our lead time typically ranges from 25 to 40 days, depending on the complexity of the design and sterilization requirements.
